Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

Evaluation of afferent pain pathways in adrenomyeloneuropathic patients

(2018) Sara Yagüe et al.   CLINICAL NEUROPHYSIOLOGY

Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy

(2018) Pablo Ranea‐Robles et al.   EMBO Molecular Medicine

Newborn Screening and Emerging Therapies for X-Linked Adrenoleukodystrophy

(2018) Ann B. Moser et al.   JAMA Neurology

Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis

(2018) Andrés Trostchansky et al.   Frontiers in Molecular Neuroscience

Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy

(2018) Bela R. Turk et al.   ANNALS OF NEUROLOGY

Oxidative Stress Treatment for Clinical Trials in Neurodegenerative Diseases

(2018) Elena Caldarazzo Ienco et al.   JOURNAL OF ALZHEIMERS DISEASE

Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy

(2017) Florian Eichler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer’s disease mice

(2017) Cheng Zhang et al.   PLoS One

Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy

(2017) Bela R. Turk et al.   JAMA Neurology

Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy

(2016) Nathalie Launay et al.   ACTA NEUROPATHOLOGICA

Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study

(2016) Hélène Blasco et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinson's disease

(2016) Jonica Campolo et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

(2016) Andrew T Drysdale et al.   NATURE MEDICINE

Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy

(2015) Marion Deon et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Abnormalities of motor function, transcription and cerebellar structure in mouse models ofTHAP1dystonia

(2015) Marta Ruiz et al.   HUMAN MOLECULAR GENETICS

Penalized regression procedures for variable selection in the potential outcomes framework

(2015) Debashis Ghosh et al.   STATISTICS IN MEDICINE

Regularization Paths for Generalized Linear Models via Coordinate Descent

(2015) Jerome Friedman et al.   Journal of Statistical Software

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy

(2014) Nathalie Launay et al.   ACTA NEUROPATHOLOGICA

X-linked adrenoleukodystrophy in women: a cross-sectional cohort study

(2014) Marc Engelen et al.   BRAIN

X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment

(2014) Marc Engelen et al.   Current Neurology and Neuroscience Reports

Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases

(2013) Shambhunath Bose et al.   ARCHIVES OF PHARMACAL RESEARCH

Oxidative stress regulates the ubiquitin–proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy

(2013) Nathalie Launay et al.   BRAIN

Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy

(2013) J. López-Erauskin et al.   HUMAN MOLECULAR GENETICS

Glutathione imbalance in patients with X-linked adrenoleukodystrophy

(2013) Sara Petrillo et al.   MOLECULAR GENETICS AND METABOLISM

Cerebrospinal Fluid Neopterin Analysis in Neuropediatric Patients: Establishment of a New Cut Off-Value for the Identification of Inflammatory-Immune Mediated Processes

(2013) Marta Molero-Luis et al.   PLoS One

Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy

(2012) Jone López-Erauskin et al.   BRAIN

Clinical usefulness of laser evoked potentials

(2012) M. Valeriani et al.   NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY

Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity

(2012) Troy C. Lund et al.   PLoS One

Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy

(2011) Jone López-Erauskin et al.   ANNALS OF NEUROLOGY

Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-Adrenoleukodystrophy

(2011) Jorge Galino et al.   ANTIOXIDANTS & REDOX SIGNALING

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy

(2011) Agatha Schlüter et al.   HUMAN MOLECULAR GENETICS

Pathomechanisms Underlying X-Adrenoleukodystrophy: A Three-Hit Hypothesis

(2010) Inderjit Singh et al.   BRAIN PATHOLOGY

General Aspects and Neuropathology of X-Linked Adrenoleukodystrophy

(2010) Isidro Ferrer et al.   BRAIN PATHOLOGY

Current and Future Pharmacological Treatment Strategies in X-Linked Adrenoleukodystrophy

(2010) Johannes Berger et al.   BRAIN PATHOLOGY

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy

(2010) Stéphane Fourcade et al.   HUMAN MOLECULAR GENETICS

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Head trauma can initiate the onset of adreno-leukodystrophy

(2009) Gerald V. Raymond et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor  /  Agonist

(2009) S. Naruhn et al.   MOLECULAR PHARMACOLOGY

The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters

(2008) Carlo W. T. van Roermund et al.   FASEB JOURNAL

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

(2008) S. Fourcade et al.   HUMAN MOLECULAR GENETICS